Rindopepimut
id:
rindopepimut-295-6495604
title:
Rindopepimut
text:
Rindopepimut (CDX-110) is an injectable peptide cancer vaccine which targets a mutant protein called EGFRvIII present in about 25% to 30% of glioblastoma cases. The vaccine consists of the EGFRv3-specific peptide conjugated to the non-specific immunomodulator keyhole limpet hemocyanin (KLH). The US FDA granted it Breakthrough Therapy designation for glioblastoma in Feb 2015 meaning that it might be able to get approval sooner if it is effective.
brand slug:
wiki
category slug:
encyclopedia
description:
Injectable peptide cancer vaccine
original url:
https://en.wikipedia.org/wiki/Rindopepimut
date created:
date modified:
2024-04-24T23:17:16Z
main entity:
{"identifier":"Q25104603","url":"https://www.wikidata.org/entity/Q25104603"}
image:
fields total:
13
integrity:
14